HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now .
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now .